TradeWorx’s Biogen BIIB Stock Holding History

TradeWorx’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,254	Closed	-$384K	–	342
2014 Q1	$384K	Sell	1,254 -2,201	-64%	-$699K	0.34%	110
2013 Q4	$967K	Buy	+3,455	New	+$894K	0.42%	49
2013 Q3	–	Sell	-3,040	Closed	-$654K	–	423
2013 Q2	$654K	Buy	+3,040	New	+$650K	0.28%	109

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeWorx's BIIB Position: Q2 2014 in Review

TradeWorx sold out of Biogen (BIIB) in Q2 2014, closing a stake of 1,254 shares — an estimated $384K sold.

TradeWorx first reported a position in BIIB in Q2 2013 and held it in 3 quarters. The position peaked at $967K in Q4 2013. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

TradeWorx reported no remaining Biogen position as of Q2 2014 after selling out during the quarter.
TradeWorx sold 1,254 Biogen shares in Q2 2014, an estimated $384K.
TradeWorx first reported a position in Biogen in Q2 2013 and held it in 3 quarters.
TradeWorx's Biogen position peaked at $967K in Q4 2013.
782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on TradeWorx's 13F filing for Q2 2014, filed 10 Jul 2014.